Search Tag: heart failure

Cardiology Management

The-underestimated-risk-of-valvular-heart-disease

2021 06 Jul

According to findings from a study published in the British Journal of Medicine, the development of valvular heart disease in patients with chronic heart failure is underestimated and rarely treated.  In the past, mitral regurgitation has been interpreted as part of the progression of heart failure rather than a treatable disease in its own right....Read more

Cardiology Management

Statins-reduce-risk-of-cancer-in-heart-failure-patients

2021 29 Jun

New findings published in the European Heart Journal report that statin use among patients with heart failure is associated with a 16% lower risk of developing cancer compared with non-statin users. Findings also show that statin use was associated with a 26% reduced risk of dying from cancer. There is sufficient clinical evidence to show that...Read more

Cardiology Management

Heart-failure-awareness-days-may-2021

2021 10 May

H eart Failure Awareness Days (HFAD) are held every year in May . The goal is to increase awareness about  heart failure and highlight the importance of recognising symptoms early, getting an accurate diagnosis and providing heart failure patients optimal treatment. This year, because of COVID-19, Heart Failure Awareness Days have gone digital....Read more

Cardiology Management

Hfsa-annual-scientific-meeting-2021

2021 10 Sep

Hybrid Event Find HFSA On Social Media Read more

Cardiology Management

More-sedentary-time-higher-risk-of-heart-failure-in-women

2020 30 Nov

Even with regular physical activity, older women (ages 50-79) who spend more waking hours in sedentary behaviors, such as sitting or lying down, have an increased risk of heart failure serious enough to require hospitalisation, according to new research.  To determine if increased sedentary time raised the risk of increased heart failure in older...Read more

Cardiology Management

Esccongress-vaccines-against-respiratory-infections-reduce-heart-failure-deaths

2020 29 Aug

According to new findings presented at the ESC Congress 2020, influenza and pneumonia vaccinations are associated with fewer hospital deaths in heart failure patients.  Approximately 26 million people are affected with heart failure worldwide. It is estimated that one out of five individuals will develop heart failure in their lifetime. Heart failure...Read more

Cardiology Management

Covid-19-dangerous-cardiovascular-complications

2020 18 May

COVID-19 can cause serious cardiovascular complications including heart failure, heart attacks and blood clots that can lead to strokes, emergency medicine doctors report in a new scientific paper. They also caution that COVID-19 treatments can interact with medicines used to manage patients' existing cardiovascular conditions. The new paper from...Read more

ICU Management

New-onset-of-atrial-fibrillation-in-the-icu-a-special-challenge-for-heart-failure-patients-1

2020 23 Apr

Atrial fibrillation (AF) is the most common heartbeat irregularity and associated with development of stroke, myocardial infarction and heart failure. Vice versa, the structural and neurohormonal changes in heart failure (HF), when the contractility of the heart muscle is reduced, make the development and progression of AF much more likely.  HF itself...Read more

Executive Health Management

Heart-failure-noninvasive-hemodynamic-monitoring-on-the-rise

2020 09 Mar

Heart Failure (HF) is a major and public health problem as it affects at least 26 million people worldwide and will dramatically increase with an ageing population. Currently 5.7 million people suffer from HF in the US with an expected 46% increase in prevalence by 2030.[1] This is an alarming number especially when accounting for increasing health...Read more

Cardiology Management

Innovation-in-heart-failure-from-pills-to-devices

2020 27 Feb

Heart failure is a common disorder affecting millions of people globally. Over the past three decades, the prevalence of heart failurehas been increasing primarily because of the advancing age of the population and advances in medicine, which is allowing patients with hypertension, myocardial infarction, end-stage renal disease, and diabetes to live...Read more

Executive Health Management

Bright-ideas

2020 29 Jan

HealthManagement.org rounds up exciting developments that have all the characteristics of game-changers for healthcare. What do you think? AI Breast Cancer Diagnosis Matches Two Doctors A study suggested that AI diagnoses breast cancer from mammograms more accurately than radiologists.A computer, specially designed and trained by...Read more

Cardiology Management

Beta-blockers-and-heart-failure-hospitalisations

2019 07 Dec

Nearly six million Americans have heart failure, a leading driver of health care costs in the United States. The "stiff heart" heart failure variant accounts for about half of all cases and the vast majority of such patients take beta-blocker medications despite unclear benefit from their regular use. A new publication in JAMA Network Open links use...Read more

Cardiology Management

Machine-learning-helps-predict-risk-of-heart-failure

2019 20 Sep

Heart failure is a common complication in patients suffering from Type 2 Diabetes (T2D). Recently, new medicines have been developed to offset these risks; however, finding effective strategies to identify which T2D patients are most at risk has been difficult.    Researchers at Brigham and Women’s Hospital and UT Southwestern Medical Centre have...Read more

Cardiology Management

Esccongress-paragon-hf-trial-misses-endpoint

2019 01 Sep

Findings from the PARAGON-HF trial were presented in the first hot-line session at the ESC Congress today in Paris. Investigators from Brigham and Women's Hospital presented the results of the Prospective Comparison of ARNI with ARB Global Outcome in HF With Preserved Ejection Fraction (PARAGON-HF). This is the largest, randomised clinical trial...Read more

Cardiology Management

Esccongress-preview-dapa-hf-trial

2019 29 Aug

The DAPA-HF trial is the first heart failure outcomes trial with dapagliflozin, an SGLT2 inhibitor, in patients with and without Type-2 diabetes. Findings from the trial will be presented at the ESC Congress next week.  DAPA-HF is an international, multi-centre, parallel-group, randomised, double-blind trial in patients with heart failure...Read more

Executive Health Management

The-future-of-cardiovascular-disease-treatment-and-management

2019 26 Aug

Arthur M. Feldman, MD, PhD, Laura H. Carnell Professor of Medicine at the Lewis Katz School of Medicine at Temple University, has been recognised with the 2019 Distinguished Scientist Award-Basic Domain by the American College of Cardiology. Prof. Feldman has received this honour due to his contribution towards improving cardiovascular health and...Read more

Cardiology Management

Inotropic-agents-for-heart-failure-wishful-thinking

2019 26 Aug

Summary: Calcium activation and calcium sensitivity in the failing myocardium.   Historically, treatment of heart failure with inotropic agents started with the employment of extracts of foxglove, which contained a mixture of cardiac glycosides. With their low therapeutic margin due to a resulting ionic dysbalance though, cardiac glycosides...Read more

Cardiology Management

Esccongress-preview-paragon-hf-trial

2019 10 Aug

Topline findings from the Phase III PARAGON-HF study have just been announced. Full results of the trial will be presented at the ESC Congress 2019 in September.  The  PARAGON-HF trial  in heart failure patients with preserved ejection fraction (HFPEF) investigates the safety and efficacy of sacubitril/valsartan versus the active comparator...Read more

Cardiology Management

Heart-failure-2020

2020 23 May

HEART FAILURE 2020 HAS BEEN CANCELLED DUE TO COVID-19 HEALTH CONCERNS  Find ESC on Social Media Read more

Cardiology Management

Smoking-and-risk-of-cardiovascular-disease

2019 08 Jul

The most in-depth study in the world on smoking risks to cardiovascular health reveals 17 Australian smokers die each day from heart attacks, strokes and other cardiovascular conditions.  The Australian National University (ANU) conducted a study, in partnership with the Heart Foundation and the Sax Institute, with 190,000 Australian smokers and...Read more

Cardiology Management

Europcr-2020

2020 19 May

CANCELLED DUE TO COVID-19 HEALTH CONCERNS Find PCR on Social Media   Read more

Cardiology Management

Shared-decision-making-and-cardiovascular-care

2019 20 Jun

As the focus on patient-centred care increases, healthcare authorities are trying their best to establish progressive programmes and policies that encourage clinicians to integrate approaches that consider patient needs first. For example, US Centers for Medicare and Medicaid have embedded policies in 2019 that offer incentives to healthcare providers...Read more

Executive Health Management

Precision-health-and-population-health-can-they-intersect-effectively

2019 22 May

How and where can precision medicine and public health join forces to improve patient care and outcomes and, ultimately, lead to more efficient healthcare. HealthManagement.org spoke to four precision medicine experts for their views. You might also like: Precision Medicine: the future of health   Tienush Rassaf  Department Head...Read more

IMAGING Management

Icnc2019-machine-learning-predicts-sudden-death-in-heart-failure-patient-for-the-first-time

2019 14 May

Artificial intelligence ( AI ) has shown promise to select heart failure patients for expensive treatments to prevent lethal arrhythmias , reports a study presented at ICNC 2019. The study is the first to use a machine learning algorithm to predict sudden death in heart failure patients . The International Conference on Nuclear Cardiology and...Read more

Cardiology Management

Urgent-need-to-look-after-hearts-of-cancer-patients

2019 08 May

Many physicians are not telling cancer patients about the cardiotoxicity risks of treatments and may not be fully aware of the dangers themselves. A new study reveals an urgent need to look after the hearts of these patients. The research is presented today at EuroHeartCare 2019. "There was no mention that it could lead to heart disease. Would...Read more

Cardiology Management

Landmark-heart-failure-trials-under-represent-women

2019 10 Apr

A new analysis suggests that women are under-represented in landmark heart failure clinical trials. In the PARADIGM-HF trial, the use of sacubitril-valsartan reduced heart failure hospitalisations as well as cardiovascular death by 20% compared to enalapril. However, only 21% of the study participants were women. In the inclusion criteria for the...Read more

Cardiology Management

Heart-failure-patients-do-not-take-guideline-recommended-drugs

2019 10 Apr

Heart failure patients who could possibly benefit from a newer class of drug to lower their heart rate were more likely to take the medication if it was prescribed before hospital discharge rather than in a follow-up doctor's visit, according to preliminary research presented at the American Heart Association's Quailty of Care and Outcomes Research...Read more

Cardiology Management

Ehra2019-heart-failure-patients-remote-monitoring-prevents-hospitalisations

2019 27 Mar

Late-breaking findings from the RESULT trial presented at EHRA 2019, a European Society of Cardiology (ESC) congress, demonstrate that remote monitoring of heart failure patients is effective in keeping them out of hospital. In fact, this innovative strategy has won reimbursement from the national health system.     Around 1-2% of adults...Read more

Cardiology Management

Endogenous-testosterone-and-thromboembolism-heart-failure-myocardial-infarction

2019 15 Mar

Testosterone replacement therapy (TRT) prescriptions have shown a decline in the U.S. but still remain well above levels needed to treat pathological hypogonadism. Over the years, the use of anabolic steroids has expanded from athletes to the general population.  With respect to current clinical data, it is unclear whether testosterone has...Read more

Cardiology Management

In-hospital-initiation-of-angiotensin-receptor-neprilysin-inhibitors

2019 15 Mar

Heart failure (HF) is a major health problem and results in significant morbidity and mortality. The use of Angiotensin Receptor-Neprilysin Inhibitor (ARNI) in patients hospitalised for HF may be a good strategy to improve morbidity and mortality in patients with heart failure with reduced ejection fraction (HFrEF). Different studies have...Read more